Assenagon Asset Management S.A. Myriad Genetics Inc Transaction History
Assenagon Asset Management S.A.
- $60.5 Billion
- Q2 2025
A detailed history of Assenagon Asset Management S.A. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 325,030 shares of MYGN stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
325,030
Previous 84,387
285.17%
Holding current value
$1.96 Million
Previous $748,000
130.61%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding MYGN
# of Institutions
233Shares Held
94.1MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$91.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$55.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$29.7 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$29 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$27.7 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $486M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...